392 related articles for article (PubMed ID: 9016587)
1. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
Verhoef K; Tijms M; Berkhout B
Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
[TBL] [Abstract][Full Text] [Related]
2. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat.
Yang L; Morris GF; Lockyer JM; Lu M; Wang Z; Morris CB
Virology; 1997 Aug; 235(1):48-64. PubMed ID: 9300036
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
[TBL] [Abstract][Full Text] [Related]
4. Tat functions to stimulate the elongation properties of transcription complexes paused by the duplicated TAR RNA element of human immunodeficiency virus 2.
García-Martínez LF; Mavankal G; Peters P; Wu-Baer F; Gaynor RB
J Mol Biol; 1995 Dec; 254(3):350-63. PubMed ID: 7490754
[TBL] [Abstract][Full Text] [Related]
5. Exon2 of HIV-2 Tat contributes to transactivation of the HIV-2 LTR by increasing binding affinity to HIV-2 TAR RNA.
Rhim H; Rice AP
Nucleic Acids Res; 1994 Oct; 22(21):4405-13. PubMed ID: 7971271
[TBL] [Abstract][Full Text] [Related]
6. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
7. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
[TBL] [Abstract][Full Text] [Related]
8. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
Murphy KM; Sweet MJ; Ross IL; Hume DA
J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
10. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication.
Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J
J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193
[TBL] [Abstract][Full Text] [Related]
11. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185.
Wu F; Garcia J; Sigman D; Gaynor R
Genes Dev; 1991 Nov; 5(11):2128-40. PubMed ID: 1936997
[TBL] [Abstract][Full Text] [Related]
12. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
[TBL] [Abstract][Full Text] [Related]
13. Examination of TAR-independent Trans activation by human immunodeficiency virus type 1 Tat in human glial cells.
Kim YS; Panganiban AT
J Neurosci Res; 1996 Mar; 43(6):652-66. PubMed ID: 8984195
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2'-O-methyl/LNA oligoribonucleotides.
Arzumanov A; Walsh AP; Rajwanshi VK; Kumar R; Wengel J; Gait MJ
Biochemistry; 2001 Dec; 40(48):14645-54. PubMed ID: 11724578
[TBL] [Abstract][Full Text] [Related]
15. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression.
Lisziewicz J; Rappaport J; Dhar R
New Biol; 1991 Jan; 3(1):82-9. PubMed ID: 2039768
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
Roebuck KA; Rabbi MF; Kagnoff MF
AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
[TBL] [Abstract][Full Text] [Related]
17. Transactivation of heterologous promoters by HIV-1 tat.
Han P; Brown R; Barsoum J
Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
19. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
[TBL] [Abstract][Full Text] [Related]
20. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter.
Berkhout B; Gatignol A; Rabson AB; Jeang KT
Cell; 1990 Aug; 62(4):757-67. PubMed ID: 2201451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]